Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberta Hoi

Showing results (61-70 of 83) with videos related to

Pageof 9
Sort By:
Lupus Science & Medicine|July 8, 2025
Informing trial measurement in systemic lupus erythematosus: frequency of domain-specific disease activity in a multinational cohortRaychel Barallon, Kathryn Connelly, Vera Golder, et al.
The Lancet. Rheumatology|June 14, 2024
Association of sustained lupus low disease activity state with improved outcomes in systemic lupus erythematosus: a multinational prospective cohort studyVera Golder, Rangi Kandane-Rathnayake, Ning Li, et al.
Arthritis Research & Therapy|March 15, 2022
'Not at target': prevalence and consequences of inadequate disease control in systemic lupus erythematosus-a multinational observational cohort studyRangi Kandane-Rathnayake, Worawit Louthrenoo, Alberta Hoi, et al.
Rheumatology (Oxford, England)|November 18, 2025
Predictors of damage accrual by organ domain in systemic lupus erythematosusRangi Kandane-Rathnayake, Luigi Zolio, JIyoon Choi, et al.
ACR Open Rheumatology|February 27, 2025
Frequency and Determinants of Flare and Persistently Active Disease in a Large Multinational Prospective Lupus CohortYanjie Hao, Dylan Hansen, Worawit Louthrenoo, et al.
Lupus Science & Medicine|November 11, 2025
Impact of glucocorticoid dose threshold in definition of lupus low disease activity state: a multinational observational cohort studyRangi Kandane-Rathnayake, Alberta Hoi, Worawit Louthrenoo, et al.
Arthritis Research & Therapy|July 23, 2025
Prevalence and outcomes of a pilot definition of severe refractory systemic lupus erythematosus: observations from a multinational Asia-Pacific cohortRangi Kandane-Rathnayake, Worawit Louthrenoo, C S Lau, et al.
Arthritis Care & Research|September 16, 2025
Prevalence, Determinants, and Outcomes of Low Disease Activity and Remission Attainment in Patients With Systemic Lupus Erythematosus That Is Clinically ActiveYanjie Hao, Dylan Hansen, Rangi Kandane-Rathnayake, et al.
Lupus Science & Medicine|February 12, 2025
Time trends of variability in disease activity in systemic lupus erythematosusNing Li, Alberta Hoi, Shue-Fen Luo, et al.
Seminars in Arthritis and Rheumatism|January 28, 2024
OMERACT 2023 Systemic Lupus Erythematosus Special Interest Group: Winnowing and Binning Preliminary Candidate Domains for the Core Outcome SetWils Nielsen, Vibeke Strand, Lee S Simon, et al.
Pageof 9

Showing results (61-70 of 83) with videos related to

Sort By:
Pageof 9
Lupus Science & Medicine|July 8, 2025
Informing trial measurement in systemic lupus erythematosus: frequency of domain-specific disease activity in a multinational cohortRaychel Barallon, Kathryn Connelly, Vera Golder, et al.
The Lancet. Rheumatology|June 14, 2024
Association of sustained lupus low disease activity state with improved outcomes in systemic lupus erythematosus: a multinational prospective cohort studyVera Golder, Rangi Kandane-Rathnayake, Ning Li, et al.
Arthritis Research & Therapy|March 15, 2022
'Not at target': prevalence and consequences of inadequate disease control in systemic lupus erythematosus-a multinational observational cohort studyRangi Kandane-Rathnayake, Worawit Louthrenoo, Alberta Hoi, et al.
Rheumatology (Oxford, England)|November 18, 2025
Predictors of damage accrual by organ domain in systemic lupus erythematosusRangi Kandane-Rathnayake, Luigi Zolio, JIyoon Choi, et al.
ACR Open Rheumatology|February 27, 2025
Frequency and Determinants of Flare and Persistently Active Disease in a Large Multinational Prospective Lupus CohortYanjie Hao, Dylan Hansen, Worawit Louthrenoo, et al.
Lupus Science & Medicine|November 11, 2025
Impact of glucocorticoid dose threshold in definition of lupus low disease activity state: a multinational observational cohort studyRangi Kandane-Rathnayake, Alberta Hoi, Worawit Louthrenoo, et al.
Arthritis Research & Therapy|July 23, 2025
Prevalence and outcomes of a pilot definition of severe refractory systemic lupus erythematosus: observations from a multinational Asia-Pacific cohortRangi Kandane-Rathnayake, Worawit Louthrenoo, C S Lau, et al.
Arthritis Care & Research|September 16, 2025
Prevalence, Determinants, and Outcomes of Low Disease Activity and Remission Attainment in Patients With Systemic Lupus Erythematosus That Is Clinically ActiveYanjie Hao, Dylan Hansen, Rangi Kandane-Rathnayake, et al.
Lupus Science & Medicine|February 12, 2025
Time trends of variability in disease activity in systemic lupus erythematosusNing Li, Alberta Hoi, Shue-Fen Luo, et al.
Seminars in Arthritis and Rheumatism|January 28, 2024
OMERACT 2023 Systemic Lupus Erythematosus Special Interest Group: Winnowing and Binning Preliminary Candidate Domains for the Core Outcome SetWils Nielsen, Vibeke Strand, Lee S Simon, et al.
Pageof 9